Serum levels of TNF-α and IL-6 in patients with diabetic nephropathy

Journal Title: INTERNATIONAL JOURNAL OF CURRENT RESEARCH - Year 2016, Vol 8, Issue 5

Abstract

Background: Diabetic nephropathy (DN) is one of the chronic complications of diabetes mellitus (DM) that cause a common end-stage renal disease (ESRD). Cytokines regulate inflammatory processes in response to the degree of inflammations. Overproduction of pro-inflammatory cytokines such as tumor necrosis factoralpha (TNF-α) and interlukin-6 (IL-6) play a role in the development and progression of DN. Aim: To evaluate the levels of TNF-α and IL-6, and their implication in diagnosis and progression of nephropathy in patients with type 2diabetes mellitus (T2DM). Subjects and Methods: Sixty subjects (45 patients, 15 normal) were selected from Suez city and general hospital in Suez, with mean age43.3±8.2years. They were classified into four groups, Group I:healthy subjects, Group II:T2DMpatients; GroupIII: Nephropathicpatients identified by high level of creatinine in blood and microalbuminurea; and Group IV: Nephropathic patients with T2DM as identified by high level of creatinine and glucose in blood and microalbuminurea. Blood and urine samples were collected and tested for fasting and postprandial blood glucose (PBG) level, glycosylated hemoglobin (HbA1C), liver and kidney function tests. In addition, serum TNF-α, and IL-6levels were measured by Enzyme Linked Immune Sorbent Assay (ELISA). Results: The level of IL-6 was significantly increased (p<0.05) in nephropathy and DN groups compared to control and T2DM groups with a significant positive correlation between its level and the duration of diabetes in DN group and significant negative correlation between its level and duration of diabetes in T2DM group. On the other side, TNF-α levels were significantly decreased(p<0.05) in both nephropathy and DN groups compared with control and T2DM groups which was not correlate to the duration of diabetes in either T2DM or DN groups. Conclusion: Tracking the levels of IL-6 cytokine in T2DM patients could be used as a marker for progression to DN patients.

Authors and Affiliations

Nagwa Ebrahim, ABOZEID A. HASSANIEN, MAGDY Mahmud Mohamed, Gamal Ahmed Tawfik

Keywords

Related Articles

Comparative evaluation of laser, Cyanoacrylate and laser with Cyanoacrylate in the treatment of dentine hypersensitivity – A clinical study

Aim: To evaluate and compare the clinical efficacy of laser, cyanoacrylate and laser with cyanoacrylate in the treatment of dentine hypersensitivity. Materials and Methods: The study sample comprised of 150 sites out of...

Comparison of serum magnesium and hba1c levels in patients With type-2 diabetes mellitus

Introduction: Diabetes mellitus comprises a group of common metabolic disorders that share the phenotype of hyperglycemia. The metabolic dysregulation associated with DM causes secondary pathophysiologic changes in multi...

Serum gamma glutamyl transferase and magnesium as markers of oxidative stress in type2 diabetic patients

Background and Aims: Oxidative stress and adverse metabolic changes are key components of type2 diabetes mellitus. Gamma glutamyl transferase (GGT) enzyme maintains the GSH-cysteine homeostasis as well as detoxifies the...

Knowledge, awareness and practice among dental practitioners regarding oral appliances in treatment of obstructive sleep apnea

Aim: To assess the knowledge, awareness and practice among dental practitioners regarding oral appliances in treatment of obstructive sleep apnea (OSA). Objective: The objective of this study is to an...

Sensitization to mould aeroallergens in children with asthma and allergic rhinitis

Background: Approximately 80 fungus species have been reported to be connected with respiratory allergy. Moreover, it is proven that four of them are the most common: Alternaria, Cladosporium, Aspergillus, and Penicilliu...

Download PDF file
  • EP ID EP405110
  • DOI -
  • Views 138
  • Downloads 0

How To Cite

Nagwa Ebrahim, ABOZEID A. HASSANIEN, MAGDY Mahmud Mohamed, Gamal Ahmed Tawfik (2016). Serum levels of TNF-α and IL-6 in patients with diabetic nephropathy. INTERNATIONAL JOURNAL OF CURRENT RESEARCH, 8(5), 30646-30651. https://europub.co.uk./articles/-A-405110